This variability in SOX3 expression among human ovarian cancer cell lines highlights its differential behavior depending on the cell type, with metastatic cell lines showing increased SOX3 expression, potentially tying SOX3 to malignant transformations within ovarian tumors. This evidence concerns the gene SOX3 and ovarian neoplasm.